Scope Fluidics SaGPW: SCP

Scope Fluidics Extends Collaboration For FDA Certification

· TradingView

Scope Fluidics SA GPW:SCP:

  • EXTENDS COLLABORATION FOR FDA CERTIFICATION FOR BACTEROMIC SYSTEM WITH UNI FAST PANEL

  • THANKS TO EXPANSION OF COOPERATION, BACTEROMIC WILL BE ABLE TO APPLY FOR FDA CERTIFICATION IMMEDIATELY FOR THE BACTEROMIC SYSTEM WITH UNI FAST PANEL

  • BACTEROMIC TO ASSESS UP TO 52 ANTIBIOTICS AND 3 RESISTANCE MECHANISMS

  • CLINICAL STUDY COSTS INCREASE TO $3.3 MILLION FROM $2.0 MILLION DUE TO EXTENSION

  • FDA CERTIFICATION EXPECTED IN FIRST HALF OF 2027